Exeltis Pharmaceuticals Holding SL:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Exeltis Pharmaceuticals Holding SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11339
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Exeltis Pharmaceuticals Holding SL (Exeltis), a subsidiary of Insud Pharma, is a developer, producer, and marketer of medicinal products and medical devices. The company provides products in the therapeutic areas including women’s health, dermatology, respiratory, central nervous system, infectious diseases, cardiology, ophthalmology, oncology, gastroenterology, and endocrinology, among others. It works in collaboration with healthcare professionals, patients, consumers, and other pharmaceutical companies, and health authorities to carry out its pharmacovigilence activities for identifying, assessing and reporting adverse reactions of marketed drugs. The company operates in France, Spain, Turkey, Switzerland, the US, among others. Exeltis is headquartered in Madrid, Spain.

Exeltis Pharmaceuticals Holding SL – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Exeltis Acquires Juste Farma Division from Juste labs 10
Licensing Agreements 11
Exeltis Enters into Licensing Agreement with Neurim Pharma 11
Grupo Juste Enters into Licensing Agreement with RedHill Biopharma and IntelGenx 12
D&A Pharma Enters into Licensing Agreement with Grupo JUSTE 13
Asset Transactions 14
Exeltis Acquires Juste Farma Division from Juste labs 14
Bial – Portela Acquires Business Unit from Grupo Juste 15
Acquisition 16
Exeltis Acquires Embil Pharma 16
Exeltis Acquires Althea Pharma 17
Exeltis Pharmaceuticals Holding SL – Key Competitors 18
Exeltis Pharmaceuticals Holding SL – Key Employees 19
Exeltis Pharmaceuticals Holding SL – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Key Facts 2
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Exeltis Pharmaceuticals Holding SL, Deals By Therapy Area, 2012 to YTD 2018 8
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Exeltis Acquires Juste Farma Division from Juste labs 10
Exeltis Enters into Licensing Agreement with Neurim Pharma 11
Grupo Juste Enters into Licensing Agreement with RedHill Biopharma and IntelGenx 12
D&A Pharma Enters into Licensing Agreement with Grupo JUSTE 13
Exeltis Acquires Juste Farma Division from Juste labs 14
Bial - Portela Acquires Business Unit from Grupo Juste 15
Exeltis Acquires Embil Pharma 16
Exeltis Acquires Althea Pharma 17
Exeltis Pharmaceuticals Holding SL, Key Competitors 18
Exeltis Pharmaceuticals Holding SL, Key Employees 19
Exeltis Pharmaceuticals Holding SL, Other Locations 20
Exeltis Pharmaceuticals Holding SL, Subsidiaries 20

List of Figures
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Exeltis Pharmaceuticals Holding SL:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Driver Group Plc (DRV):企業の財務・戦略的SWOT分析
    Driver Group Plc (DRV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Tryton Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Tryton Medical Inc (Tryton Medical) is a medical device company that develops novel stent systems for the treatment of bifurcation lesions. The company offers tryton side branch coronary artery stent which is designed to treat, protect and secure coronary bifurcations. Its tryton side branch …
  • Israel Chemicals Ltd (ICL):企業の財務・戦略的SWOT分析
    Israel Chemicals Ltd (ICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Apollo Education Group Inc:企業の戦略的SWOT分析
    Apollo Education Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Nordic American Tankers Limited (NAT):石油・ガス:M&Aディール及び事業提携情報
    Summary Nordic American Tankers Limited (NAT) is a tanker company. It transports crude oil through its fleet of double-hull Suezmax tankers. The company operates its vessels on bareboat charters, time charters, and spot charters. NAT’s tankers are capable of carrying high volumes of oil and able to …
  • NovaDigm Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NovaDigm Therapeutics Inc (NovaDigm) is a developer of immunotherapeutics and preventative vaccines to protect patients from fungal and bacterial diseases. The company’s products include NDV-3 vaccines, vaccine clinical supplies, ALS3 vaccines, bacterial and fungal vaccine antigens, fungal a …
  • Virgin Atlantic Airways Ltd:企業の戦略・SWOT・財務情報
    Virgin Atlantic Airways Ltd - Strategy, SWOT and Corporate Finance Report Summary Virgin Atlantic Airways Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Bioverativ Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant antihemophilic factor engineered using Fc fusion technolog …
  • Eni SpA (ENI):企業の財務・戦略的SWOT分析
    Eni SpA (ENI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Altra Industrial Motion Corp (AIMC):企業の財務・戦略的SWOT分析
    Summary Altra Industrial Motion Corp (Altra Industries), formerly Altra Holdings Inc is an industrial equipment company that designs and manufactures power transmission and motion control products. The company offers products such as electric clutches and brakes, couplings, heavy duty clutches and b …
  • Rodin Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Rodin Therapeutics Inc (Rodin Therapeutics) discovers and develops novel medicines targeting epigenetics and novel chemical strategies for cognitive impairment of neurological and neuropsychiatric disorders. Its translational therapeutic strategy harnesses the power of epigenetic regulation …
  • Allegiance Capital Corporation:企業の戦略・SWOT・財務情報
    Allegiance Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary Allegiance Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Versartis Inc (VSAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Versartis Inc (Versartis) is a biopharmaceutical company that develops, manufactures and commercializes medicines for the treatment of endocrine disorders. The company’s lead product candidate include somavaratan (VRS-317) is a recombinant human growth hormone (GHD) that is designed to reduc …
  • Asahi Kasei Corp (3407)-製薬・医療分野:企業M&A・提携分析
    Summary Asahi Kasei Corp (Asahi Kasei), formerly Asahi Chemical Industry Co. Ltd., manufactures, processes, and sells chemical products. It is a holding company of Asahi Kasei Group. The product portfolio of the company includes polymers, acrylonitrile, styrene, diagnostic reagents, foam insulation …
  • Cellmid Ltd (CDY)-医療機器分野:企業M&A・提携分析
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd is a developer of therapies and diagnostic tests. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such as midkine ELISA kit, advangen international hair …
  • Visioneering Technologies Inc (VTI):企業の製品パイプライン分析2018
    Summary Visioneering Technologies Inc (VTI) is a medical device company that offers ophthalmic solutions. The company develops a portfolio of technologies to address eye care issues such as presbyopia, myopia and astigmatism. Its technology includes myopia correction technology, silicone hydrogel ma …
  • Rio Grande Electric Cooperative, Inc.:発電所・企業SWOT分析
    Rio Grande Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Getinge AB (GETI B):企業の財務・戦略的SWOT分析
    Getinge AB (GETI B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Arlington Asset Investment Corp (AI):企業の財務・戦略的SWOT分析
    Summary Arlington Asset Investment Corp (AAIC) is an investment firm that offers asset management and investment services. The firm acquires and holds mortgage-related assets. It acquires residential mortgage-backed securities issued by the US government agencies. AAIC also acquires mortgage-backed …
  • Accelerate Resources Ltd (AX8):企業の財務・戦略的SWOT分析
    Accelerate Resources Ltd (AX8) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆